InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Sabag Mark, Responsable des marchés internationaux. Officer active across 1 company, notably Teva Pharmaceutical Industries Ltd. Aggregated, 19 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €9.8m. History available since 12 February 2025. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Sabag Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
62,102 shares@ US$30.14116.5% of flowOrdinary SharesSEC:0001193125-26-115929:0
15,723 sharesOrdinary SharesSEC:0001193125-26-098582:0
33,512 sharesOrdinary SharesSEC:0001193125-26-096538:0
24,900 sharesOrdinary SharesSEC:0001193125-26-093938:0
118,724 shares@ US$18.6116.2% of flowOrdinary SharesSEC:0001193125-25-315923:0
337,915 shares@ US$18.043966.1% of flowOrdinary SharesSEC:0000950170-25-069132:0
23,765 sharesOrdinary SharesSEC:0000950170-25-035512:0
33,512 sharesOrdinary SharesSEC:0000950170-25-034617:0
24,900 sharesOrdinary SharesSEC:0000950170-25-033597:0
177,626 shares@ US$16.250833.9% of flowOrdinary SharesSEC:0000950170-25-021151:0
23,764 sharesOrdinary SharesSEC:0000950170-24-027959:0
24,900 sharesOrdinary SharesSEC:0000950170-24-025917:0
20,599 sharesOrdinary SharesSEC:0000950170-24-023528:0
33,512 sharesOrdinary SharesSEC:0001209191-23-016714:0
20,598 sharesOrdinary SharesSEC:0001209191-23-014440:0
15,920 sharesOrdinary SharesSEC:0001209191-22-017056:0
20,598 sharesOrdinary SharesSEC:0001209191-22-014472:0
15,523 sharesOrdinary SharesSEC:0001209191-22-008416:0
37,884 sharesOrdinary SharesSEC:0001209191-21-032253:0
19 of 19 declarations
About Sabag Mark
Sabag Mark is Responsable des marchés internationaux at Teva Pharmaceutical Industries Ltd. He has reported 19 filings in total, and across the recent filings available from 2021-05-13 to 2026-03-19, sales amount to EUR 9844931, with Levée d'options as the most common transaction type.
